https://clinicaltrials.gov/ct2/show/NCT02665364?type=Intr&cond=Lupus&phase=012345&lupd_s=03%2F07%2F2019&lupd_d=14
Condition : Systemic Lupus Erythematosus
Interventions : Biological: IFN-Kinoid; Other: Placebo; Other: ISA 51
Sponsor : Neovacs
Active, not recruiting
Study of IFN-K in Systemic Lupus Erythematosus
NCT02665364
Wed, 27 Jan 2016 12:00:00 EST
